Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
7.16
-0.12 (-1.65%)
At close: Sep 29, 2026, 4:00 PM EDT
7.15
-0.01 (-0.14%)
After-hours: Sep 29, 2026, 7:53 PM EDT
Solid Biosciences Market Cap
Solid Biosciences has a market cap or net worth of $767.73 million as of September 29, 2026. Its market cap has increased by 60.31% in one year.
Market Cap
767.73M
Enterprise Value
410.21M
1-Year Change
60.31%
Ranking
Category
Stock Price
$7.16
ChartMarket Cap Chart
Since January 26, 2018, Solid Biosciences's market cap has increased from $754.10M to $767.73M, an increase of 1.81%. That is a compound annual growth rate of 0.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2026 | 767.73M | 74.72% |
| Dec 31, 2025 | 439.40M | 174.97% |
| Dec 31, 2024 | 159.80M | 28.97% |
| Dec 29, 2023 | 123.90M | 205.93% |
| Dec 30, 2022 | 40.50M | -79.02% |
| Dec 31, 2021 | 193.00M | -57.88% |
| Dec 31, 2020 | 458.20M | 123.95% |
| Dec 31, 2019 | 204.60M | -78.45% |
| Dec 31, 2018 | 949.60M | 25.92% |
| Jan 26, 2018 | 754.10M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Inventiva | 793.87M |
| 4D Molecular Therapeutics | 791.65M |
| Achieve Life Sciences | 787.20M |
| Geron | 787.03M |
| Gyre Therapeutics | 784.65M |
| Aclaris Therapeutics | 783.10M |
| Design Therapeutics | 776.64M |
| Immix Biopharma | 748.30M |